Overview of regulation of the renin-angiotensin-aldosterone system

DOI Web Site 被引用文献2件 参考文献33件
  • Nishiyama Akira
    Department of Pharmacology, Faculty of Medicine, Kagawa University, Japan
  • Kim-Mitsuyama Shokei
    Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Japan

書誌事項

タイトル別名
  • New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Overview of Regulation of the Renin-Angiotensin-Aldosterone System

この論文をさがす

抄録

The critical role played by the renin–angiotensin–aldosterone system (RAAS) in the regulation of blood pressure and body fluid homeostasis has been well recognized. Angiotensin (Ang) II and aldosterone are the most powerful biologically active products of the RAAS, although there are also other bioactive Ang peptides involved in this system, including AngIII, AngIV, and Ang1 – 7. In addition to their physiological roles, AngII and aldosterone induce inflammation, cell growth, mitogenesis, apoptosis, migration, and differentiation; regulate gene expression of bioactive substances; and activate multiple intracellular signaling pathways, all of which contribute to cardiovascular tissue injury. During the last decade, both clinical and preclinical studies have demonstrated that various pharmacological interventions of the RAAS exert blood pressure–independent cardiovascular-protective effects. In this Forum Minireview entitled “New approaches to blockade of the renin–angiotensin–aldosterone system”, we will discuss the impact of RAAS inhibitors on prevention of the development of hypertension and cardiovascular diseases. Before going into details about the insights into RAAS inhibition that each of the four groups will provide, we herein briefly overview our current understanding of regulation of the circulating RAAS.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (33)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ